{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T22:11:26Z","timestamp":1778278286488,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.clinthera.2013.02.020","type":"journal-article","created":{"date-parts":[[2013,3,20]],"date-time":"2013-03-20T11:15:21Z","timestamp":1363778121000},"page":"414-424","source":"Crossref","is-referenced-by-count":21,"title":["Estimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States"],"prefix":"10.1016","volume":"35","author":[{"given":"Josh J.","family":"Carlson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan N.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger R.","family":"Dmochowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise R.","family":"Globe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle C.","family":"Colayco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean D.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2013.02.020_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/nau.20737","article-title":"Reviewing the ICS 2002 terminology report: the ongoing debate","volume":"28","author":"Abrams","year":"2009","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.clinthera.2013.02.020_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eururo.2009.04.028","article-title":"EAU guidelines on neurogenic lower urinary tract dysfunction","volume":"56","author":"Stohrer","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinthera.2013.02.020_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/nau.20870","article-title":"Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence","volume":"29","author":"Abrams","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.clinthera.2013.02.020_bib4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0022-5347(17)37254-3","article-title":"Risk factors for upper tract deterioration in chronic spinal cord injury patients","volume":"147","author":"Gerridzen","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.clinthera.2013.02.020_bib5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2008.08.048","article-title":"Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results","volume":"55","author":"Giannantoni","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinthera.2013.02.020_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-5347(17)54449-3","article-title":"Prognostic value of urodynamic testing in myelodysplastic patients","volume":"126","author":"McGuire","year":"1981","journal-title":"J Urol"},{"key":"10.1016\/j.clinthera.2013.02.020_bib7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2008.08.048","article-title":"Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results","volume":"55","author":"Giannantoni","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinthera.2013.02.020_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sc.2009.46","article-title":"Urinary incontinence in spinal cord injured individuals 10-45 years after injury","volume":"48","author":"Hansen","year":"2010","journal-title":"Spinal Cord"},{"key":"10.1016\/j.clinthera.2013.02.020_bib9","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.juro.2009.12.029","article-title":"Under treatment of overactive bladder symptoms in patients with multiple sclerosis: an ancillary analysis of the NARCOMS Patient Registry","volume":"183","author":"Mahajan","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.clinthera.2013.02.020_bib10","first-page":"163","article-title":"Disability and treatment patterns of multiple sclerosis patients in United States: a comparison of veterans and nonveterans","volume":"39","author":"Vollmer","year":"2002","journal-title":"J Rehabil Res Dev"},{"key":"10.1016\/j.clinthera.2013.02.020_bib11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/sj.sc.3101893","article-title":"Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey?","volume":"44","author":"Wyndaele","year":"2006","journal-title":"Spinal Cord"},{"key":"10.1016\/j.clinthera.2013.02.020_bib12","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00467-007-0691-z","article-title":"The neurogenic bladder: medical treatment","volume":"23","author":"Verpoorten","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clinthera.2013.02.020_bib13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1368-5031.2005.00617.x","article-title":"Persistence with antimuscarinic therapy in patients with overactive bladder","volume":"59","author":"Haab","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.clinthera.2013.02.020_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00042307-199807000-00005","article-title":"Sacral neuromodulation in the treatment of the unstable bladder","volume":"8","author":"Bosch","year":"1998","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.clinthera.2013.02.020_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0166-4328(97)00186-1","article-title":"Neuromodulation: urodynamic effects of sacral (S3) spinal nerve stimulation in patients with detrusor instability or detrusor hyperflexia","volume":"92","author":"Bosch","year":"1998","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.clinthera.2013.02.020_bib16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/sj.sc.3101033","article-title":"Long-term results of augmentation cystoplasty in spinal cord injury patients","volume":"38","author":"Chartier-Kastler","year":"2000","journal-title":"Spinal Cord"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2013.02.020_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1464-410X.2008.07820.x","article-title":"Botulinum A toxin in the treatment of neurogenic detrusor overactivity: a consolidated field of application","volume":"102","author":"Giannantoni","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.clinthera.2013.02.020_bib18","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","article-title":"Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial","volume":"60","author":"Cruz","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinthera.2013.02.020_bib19","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.juro.2012.01.125","article-title":"Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity","volume":"187","author":"Ginsberg","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.clinthera.2013.02.020_bib20","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.eururo.2008.01.007","article-title":"Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects","volume":"53","author":"Amend","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinthera.2013.02.020_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/nau.21003","article-title":"Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database","volume":"30","author":"Manack","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.clinthera.2013.02.020_bib22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0090-4295(98)00220-9","article-title":"Patient perspective of long-term outcome of augmentation cystoplasty for neurogenic bladder","volume":"52","author":"Herschorn","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.clinthera.2013.02.020_bib23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0022-5347(05)68558-8","article-title":"Sacral nerve stimulation for treatment of refractory urinary urge incontinence","volume":"162","author":"Schmidt","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.clinthera.2013.02.020_bib24","doi-asserted-by":"crossref","unstructured":"Campbell JD, Patel V, Denys P, et al. Cost-effectiveness and financial impact of botulinum toxin type A treatment for urinary incontinence due to neurogenic detrusor overactivity in multiple sclerosis patients within the French healthcare system. Paper presented at: 25th Annual European Association of Urology; April 16, 2010; Barcelona, Spain.","DOI":"10.1016\/S1569-9056(10)60095-4"},{"key":"10.1016\/j.clinthera.2013.02.020_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11136-010-9590-z","article-title":"Exploring the impact of changes in neurogenic urinary incontinence frequency and condition-specific quality of life on preference-based outcomes","volume":"19","author":"Hollingworth","year":"2010","journal-title":"Qual Life Res"},{"key":"10.1016\/j.clinthera.2013.02.020_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","article-title":"The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs","volume":"31","author":"McHorney","year":"1993","journal-title":"Med Care"},{"key":"10.1016\/j.clinthera.2013.02.020_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.clinthera.2013.02.020_bib28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","article-title":"Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review","volume":"53","author":"Karsenty","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.clinthera.2013.02.020_bib29","first-page":"527","article-title":"Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers","volume":"29","year":"2006","journal-title":"J Spinal Cord Med"},{"key":"10.1016\/j.clinthera.2013.02.020_bib30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1464-4096.2001.001206","article-title":"Augmentation cystoplasty","volume":"88","author":"Greenwell","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.clinthera.2013.02.020_bib31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1586\/14737167.8.2.165","article-title":"Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold","volume":"8","author":"Grosse","year":"2008","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.clinthera.2013.02.020_bib32","unstructured":"Analysource Online, First DataBank, Inc."},{"key":"10.1016\/j.clinthera.2013.02.020_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00345-010-0618-3","article-title":"Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity","volume":"29","author":"Padmanabhan","year":"2011","journal-title":"World J Urol"},{"key":"10.1016\/j.clinthera.2013.02.020_bib34","unstructured":"Physician Fee Schedule and Acute Inpatient Prospective Payment System. 2012."},{"key":"10.1016\/j.clinthera.2013.02.020_bib35","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.urology.2010.01.080","article-title":"Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder","volume":"76","author":"Watanabe","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.clinthera.2013.02.020_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00345-011-0669-0","article-title":"Sacral neuromodulation in patients with multiple sclerosis","volume":"30","author":"Minardi","year":"2012","journal-title":"World J Urol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813000763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813000763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T04:41:01Z","timestamp":1562820061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291813000763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0149291813000763"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2013.02.020","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}